Abstract
Bronchopulmonary dysplasia(BPD)is a common respiratory disease among preterm infants, especially among little premature infants.BPD has unique clinical, imageology and histological features.The exact etiology and pathogenesis of BPD remain unclear in current studies and there are no effective treatments.Current studies mainly focus on high-risk infants screening examination and its prevention.Predicting possible biomarkers of BPD is a research focus.This article reviews the biomarkers predicted by BPD in blood at home and abroad in recent years. Key words: Bronchopulmonary dysplasia; Preterm infants; Biomarker; Prediction
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
